HBME‐1, MOC‐31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma
- 1 April 2000
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 36 (4), 341-347
- https://doi.org/10.1046/j.1365-2559.2000.00770.x
Abstract
Aims To evaluate HBME‐1, WT1, calretinin and MOC‐31 in the differential diagnosis of pleural mesothelioma and adenocarcinoma of the lung. Methods and results Paraffin‐embedded formalin‐fixed block...Keywords
This publication has 21 references indexed in Scilit:
- In Search of a Positive lmmunohistochemical Marker for MesotheliomaAdvances in Anatomic Pathology, 1998
- The Immunohistochemical Diagnostic Panel for Epithelial MesotheliomaThe American Journal of Surgical Pathology, 1997
- HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura.Journal of Clinical Pathology, 1997
- The Genetics of Wilms TumorAdvances in Anatomic Pathology, 1997
- Calretinin: A Novel Immunocytochemical Marker for MesotheliomaThe American Journal of Surgical Pathology, 1996
- Mesothelioma‐binding antibodies: thrombomodulin, OV 632 and HBME‐1 and their use in the diagnosis of malignant mesotheliomaHistopathology, 1996
- OV 632 and MOC 31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material.Journal of Clinical Pathology, 1995
- Expression of the wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet‐derived growth factor A and insulin‐like growth factor 2 expressionGenes, Chromosomes and Cancer, 1995
- Monoclonal Antibody K1 Reacts With Epithelial Mesothelioma but not With Lung AdenocarcinomaThe American Journal of Surgical Pathology, 1992
- Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesotheliomaThe Journal of Pathology, 1991